Hanley Jr. Michael Conick
CIK: 0001791413•Chief Operating Officer
Officer
Primary company: Alto Neuroscience, Inc. (ANRO)
Hanley Jr. Michael Conick is a corporate insider (Chief Operating Officer) at Alto Neuroscience, Inc. (ANRO) filing SEC Form 4 transactions. 15 transactions across 2 companies, totaling $20,022 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Disposition | 125,000 | - | - | 0 | 7/3/2025 Filed: 7/8/2025 | Filing → | |
| Award | 125,000 | - | - | 125,000 | 7/3/2025 Filed: 7/8/2025 | Filing → | |
| Disposition | 188,000 | - | - | 0 | 7/3/2025 Filed: 7/8/2025 | Filing → | |
| Award | 188,000 | - | - | 188,000 | 7/3/2025 Filed: 7/8/2025 | Filing → | |
| Disposition | 8,000 | - | - | 0 | 7/3/2025 Filed: 7/8/2025 | Filing → | |
| Award | 8,000 | - | - | 8,000 | 7/3/2025 Filed: 7/8/2025 | Filing → | |
| Award | 125,000 | $4.20 | $525K | 125,000 | 2/5/2025 Filed: 2/7/2025 | Filing → | |
| Award | 188,000 | - | - | 188,000 | 5/20/2024 Filed: 5/22/2024 | Filing → | |
Aeglea BioTherapeutics, Inc. AGLE | Award | 500,000 | $0.00 | $0 | 500,000 | 2/23/2023 Filed: 2/24/2023 | Filing → |
Aeglea BioTherapeutics, Inc. AGLE | Award | 130,000 | $0.00 | $0 | 130,000 | 8/23/2022 Filed: 8/25/2022 | Filing → |
Aeglea BioTherapeutics, Inc. AGLE | Purchase | 28,200 | $0.71 | $20K | 36,200 | 6/8/2022 Filed: 6/10/2022 | Filing → |
Aeglea BioTherapeutics, Inc. AGLE | Award | 160,000 | $0.00 | $0 | 160,000 | 2/17/2022 Filed: 2/22/2022 | Filing → |
Aeglea BioTherapeutics, Inc. AGLE | Award | 135,000 | $0.00 | $0 | 135,000 | 2/17/2021 Filed: 2/19/2021 | Filing → |
Aeglea BioTherapeutics, Inc. AGLE | Award | 25,000 | $0.00 | $0 | 25,000 | 2/14/2020 Filed: 2/19/2020 | Filing → |
Aeglea BioTherapeutics, Inc. AGLE | Award | 130,000 | $0.00 | $0 | 130,000 | 10/21/2019 Filed: 10/23/2019 | Filing → |
Type
Disposition
Shares
125,000
Price
-
Value
-
Type
Award
Shares
125,000
Price
-
Value
-
Type
Disposition
Shares
188,000
Price
-
Value
-
Type
Award
Shares
188,000
Price
-
Value
-
Type
Disposition
Shares
8,000
Price
-
Value
-
Type
Award
Shares
8,000
Price
-
Value
-
Type
Award
Shares
125,000
Price
$4.20
Value
$525K
Type
Award
Shares
188,000
Price
-
Value
-
Aeglea BioTherapeutics, Inc.
AGLE
Type
Award
Shares
500,000
Price
$0.00
Value
$0
Aeglea BioTherapeutics, Inc.
AGLE
Type
Award
Shares
130,000
Price
$0.00
Value
$0
Aeglea BioTherapeutics, Inc.
AGLE
Type
Purchase
Shares
28,200
Price
$0.71
Value
$20K
Aeglea BioTherapeutics, Inc.
AGLE
Type
Award
Shares
160,000
Price
$0.00
Value
$0
Aeglea BioTherapeutics, Inc.
AGLE
Type
Award
Shares
135,000
Price
$0.00
Value
$0
Aeglea BioTherapeutics, Inc.
AGLE
Type
Award
Shares
25,000
Price
$0.00
Value
$0
Aeglea BioTherapeutics, Inc.
AGLE
Type
Award
Shares
130,000
Price
$0.00
Value
$0
AI Agent
Try asking...